MedTrace Logo

Structured Treatment Interruption for HIV Patients With Virologic Failure

NCT00188851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2005-09-16

No results posted yet for this study

Summary

The purpose of this study is to assess the virologic impact of switching treatment-experienced HIV-infected patients with virologic failure to a salvage regimen with or without a 12 week STI prior to the switch.

Hypothesis: A STI prior to starting a salvage regimen will result in an improved virologic response.

Conditions

Interventions

DRUG

therapeutic management strategy

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • CIHR Canadian HIV Trials Network

    collaborator NETWORK

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Mona Loutfy, MD · University Health Network, Toronto, On

  • Joel Singer, MD · Canadian Trials Network, Vancouver, B.C.

  • Janet Raboud, Dr. · Univeristy Health Network, Toronto, On

  • Stephen Shafran, MD · University of Alberta, Edmonton, Alberta

  • Bill Cameron, MD · Ottawa Hospital, Ottawa, On

  • Sylvie Trottier, MD · Clinique Medicale L'Actuel, Montreal, Quebec

  • Richard Harrigan, MD · B.C. Centre of Excellence, Vancouver, B.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2005-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00188851 on ClinicalTrials.gov